Pharma Journalist 7879 posts 0 comments

Latigo Biotherapeutics Inc. ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target pain at its source, announced its emergence…
Read More...

Ipsen announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application for Onivyde (irinotecan liposome injection) plus oxaliplatin,…
Read More...

The 6th CKD Drug Development Summit is just around the corner! This highly anticipated summit is set to bring together KOLs, industry experts, and regulators to concentrate kidney…
Read More...

Takeda announced that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and only FDA-approved oral therapy for people 11 years and…
Read More...

AbbVie announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition, ImmunoGen is now part of AbbVie. "Together with ImmunoGen, we have the…
Read More...

GSK plc announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for bepirovirsen, an investigational antisense oligonucleotide (ASO) for the…
Read More...

Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, announced a newly expanded, multi-year agreement with global biopharmaceutical leader…
Read More...

Alys Pharmaceuticals, Inc. ("Alys"), an immuno-dermatology focused company, launches with an R&D pipeline enabled by multiple platform technologies and a $100 million financing by…
Read More...

The gene therapy landscape has witnessed an unprecedented surge in advancements, with more therapies gaining FDA approval in the past year than in the previous five years combined.…
Read More...

Bristol Myers Squibb announced two regulatory acceptances for applications for neoadjuvant Opdivo (nivolumab) with chemotherapy followed by surgery and adjuvant Opdivo for the…
Read More...